Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Di Bona

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
The World Allergy Organization Journal|April 6, 2026
Response to the comment regarding our article entitled "A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma"Danilo Di Bona, Giorgio Walter Canonica
Current Opinion in Allergy and Clinical Immunology|August 13, 2019
Is immunotherapy with fungal vaccines effective?Danilo Di Bona, Marcello Albanesi, Luigi Macchia
Plos One|May 15, 2020
A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapyMassimo Bilancia, Giuseppe Pasculli, Danilo Di Bona
Clinical and Molecular Allergy : CMA|December 12, 2022
Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccineDanilo Di Bona, Andrea Miniello, Eustachio Nettis
Allergy|August 31, 2024
Transcriptomic in allergy-statistical recommendationsMichal Ordak, Danilo Di Bona, Gaetano Serviddio
Journal of Hepatology|January 8, 2004
Interferon-alpha for HBeAg-positive chronic hepatitis BAntonio Craxì, Danilo Di Bona, Calogero Cammà
Current Pharmaceutical Design|July 29, 2004
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approachCalogero Cammà, Danilo Di Bona, Antonio Craxì
Current Opinion in Allergy and Clinical Immunology|June 27, 2024
Editorial: pharmacotherapy and evidence-based medicineGiovanni Paoletti, Federica Buta, Danilo Di Bona
European Journal of Internal Medicine|September 18, 2015
Efficacy but not effectiveness of sublingual immunotherapy for grass pollen allergy: Time to avoid waste in health-care expenditureSalvatore Corrao, Danilo Di Bona, Gabriele Di Lorenzo
The Journal of Allergy and Clinical Immunology|April 17, 2016
ReplyDanilo Di Bona, Antonella Plaia, Gabriele Di Lorenzo
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
The World Allergy Organization Journal|April 6, 2026
Response to the comment regarding our article entitled "A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma"Danilo Di Bona, Giorgio Walter Canonica
Current Opinion in Allergy and Clinical Immunology|August 13, 2019
Is immunotherapy with fungal vaccines effective?Danilo Di Bona, Marcello Albanesi, Luigi Macchia
Plos One|May 15, 2020
A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapyMassimo Bilancia, Giuseppe Pasculli, Danilo Di Bona
Clinical and Molecular Allergy : CMA|December 12, 2022
Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccineDanilo Di Bona, Andrea Miniello, Eustachio Nettis
Allergy|August 31, 2024
Transcriptomic in allergy-statistical recommendationsMichal Ordak, Danilo Di Bona, Gaetano Serviddio
Journal of Hepatology|January 8, 2004
Interferon-alpha for HBeAg-positive chronic hepatitis BAntonio Craxì, Danilo Di Bona, Calogero Cammà
Current Pharmaceutical Design|July 29, 2004
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approachCalogero Cammà, Danilo Di Bona, Antonio Craxì
Current Opinion in Allergy and Clinical Immunology|June 27, 2024
Editorial: pharmacotherapy and evidence-based medicineGiovanni Paoletti, Federica Buta, Danilo Di Bona
European Journal of Internal Medicine|September 18, 2015
Efficacy but not effectiveness of sublingual immunotherapy for grass pollen allergy: Time to avoid waste in health-care expenditureSalvatore Corrao, Danilo Di Bona, Gabriele Di Lorenzo
The Journal of Allergy and Clinical Immunology|April 17, 2016
ReplyDanilo Di Bona, Antonella Plaia, Gabriele Di Lorenzo
Pageof 14